Literature DB >> 9864221

Compensation for decreased expression of B7 molecules on Leishmania infantum-infected canine macrophages results in restoration of parasite-specific T-cell proliferation and gamma interferon production.

E Pinelli1, V P Rutten, M Bruysters, P F Moore, E J Ruitenberg.   

Abstract

Infection of humans and dogs by Leishmania infantum may result in visceral leishmaniasis, which is characterized by impaired T-cell-mediated immune responses to parasite antigens. Dogs are natural hosts of Leishmania parasites and play an important role in the transmission of the parasites to humans. In an effort to characterize the immune response in dogs infected with this intracellular pathogen, we examined how infection with L. infantum affects canine macrophages and the consequences for T-cell activation in vitro. We showed that the proliferation of T-cell lines to cognate antigen decreases to background levels when infected autologous monocyte-derived macrophages are used as antigen-presenting cells (APC). The observed reduction of antigen-specific T-cell proliferation was shown to be dependent on the parasite load and to require cell-to-cell interaction of T cells with the infected APC. In addition, we observed a decreased expression of costimulatory B7 molecules on infected monocyte-derived macrophages. The expression of other surface molecules involved in T-cell activation, such as major histocompatibility complex class I and class II, on these cells did not change upon infection, whereas the expression of intracellular adhesion molecule 1 was marginally increased. Compensation for the decreased expression of B7 molecules by the addition of B7-transfected cells resulted in the restoration of cell proliferation and gamma interferon (IFN-gamma) production by a Leishmania-specific T-cell line. These results showed that for the activation of parasite-specific canine T cells producing IFN-gamma, which are most likely involved in protective immunity, sufficient expression of B7 molecules on infected macrophages is required. Provision of costimulatory molecules may be an approach for immunotherapy of leishmaniaisis as well as for vaccine development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9864221      PMCID: PMC96302     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Regulatory properties of LFA-1 alpha and beta chains in human T-lymphocyte activation.

Authors:  C van Noesel; F Miedema; M Brouwer; M A de Rie; L A Aarden; R A van Lier
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

2.  An analysis of T cell responsiveness in Indian kala-azar.

Authors:  D L Sacks; S L Lal; S N Shrivastava; J Blackwell; F A Neva
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

3.  Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages.

Authors:  E Handman; R Ceredig; G F Mitchell
Journal:  Aust J Exp Biol Med Sci       Date:  1979-02

4.  Control of macrophage Ia expression in neonatal mice--role of a splenic suppressor cell.

Authors:  D S Snyder; C Y Lu; E R Unanue
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

5.  Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis.

Authors:  J P Haldar; S Ghose; K C Saha; A C Ghose
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

6.  Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.

Authors:  E M Carvalho; R S Teixeira; W D Johnson
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

7.  Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.

Authors:  N E Reiner
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

8.  Class II antigens on canine T lymphocytes.

Authors:  R F Doveren; W A Buurman; B Schutte; G Groenewegen; C J van der Linden
Journal:  Tissue Antigens       Date:  1985-05

9.  Immunosuppression in Kenyan visceral leishmaniasis.

Authors:  M Ho; D K Koech; D W Iha; A D Bryceson
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

10.  Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products.

Authors:  N E Reiner; W Ng; W R McMaster
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

View more
  14 in total

1.  Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology.

Authors:  L Solano-Gallego; P Morell; M Arboix; J Alberola; L Ferrer
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Influence of costimulatory molecules on immune response to Leishmania major by human cells in vitro.

Authors:  C I Brodskyn; G K DeKrey; R G Titus
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

3.  Genome-Wide Association Study of Cell-Mediated Response in Dogs Naturally Infected by Leishmania infantum.

Authors:  Luís F S Batista; Yuri T Utsunomiya; Thaís B F Silva; Raíssa A Dias; Thaise Y Tomokane; Acácio D Pacheco; Vânia L R da Matta; Fernando T Silveira; Mary Marcondes; Cáris M Nunes; Márcia D Laurenti
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

4.  Suppression of canine myeloid cells by soluble factors from cultured canine tumor cells.

Authors:  J Wasserman; L Diese; Z VanGundy; C London; W E Carson; T L Papenfuss
Journal:  Vet Immunol Immunopathol       Date:  2011-12-28       Impact factor: 2.046

5.  Expression of regulatory T cells in jejunum, colon, and cervical and mesenteric lymph nodes of dogs naturally infected with Leishmania infantum.

Authors:  Maria M Figueiredo; Beatriz Deoti; Izabela F Amorim; Aldair J W Pinto; Andrea Moraes; Carolina S Carvalho; Sydnei Magno da Silva; Ana C B de Assis; Ana M C de Faria; Wagner L Tafuri
Journal:  Infect Immun       Date:  2014-06-16       Impact factor: 3.441

6.  Differential CD86 and CD40 co-stimulatory molecules and cytokine expression pattern induced by Trypanosoma cruzi in APCs from resistant or susceptible mice.

Authors:  L Planelles; M C Thomas; C Marañón; M Morell; M C López
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

7.  Toward diagnosing Leishmania infantum infection in asymptomatic dogs in an area where leishmaniasis is endemic.

Authors:  D Otranto; P Paradies; D de Caprariis; D Stanneck; G Testini; F Grimm; P Deplazes; G Capelli
Journal:  Clin Vaccine Immunol       Date:  2009-01-07

8.  Immunotherapy Using Autoclaved L. major Antigens and M. vaccae with Meglumine Antimoniate, for the Treatment of Experimental Canine Visceral Leishmaniasis.

Authors:  Sh Jamshidi; R Avizeh; M Mohebali; S Bokaie
Journal:  Iran J Parasitol       Date:  2011-08       Impact factor: 1.012

9.  Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis.

Authors:  J Moreno; J Nieto; S Masina; C Cañavate; I Cruz; C Chicharro; E Carrillo; S Napp; C Reymond; P M Kaye; D F Smith; N Fasel; J Alvar
Journal:  Vaccine       Date:  2007-06-04       Impact factor: 3.641

10.  In vitro binding and survival assays of Leishmania parasites to peripherical blood monocytes and monocyte-derived macrophages isolated from dogs naturally and experimentally infected with Leishmania (Leishmania) chagasi.

Authors:  Weverton M Sampaio; Eliane P Moura; Felipe C S Arruda; Raul R Ribeiro; Cíntia F Alves; Ferdinan A Melo; Ana Paula S M Fernandes; Marilene S M Michalick; Maria N Melo; Washington L Tafuri; Wagner L Tafuri
Journal:  BMC Vet Res       Date:  2007-05-30       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.